Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 02, 2020

SELL
$1.5 - $9.38 $3,675 - $22,981
-2,450 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$4.79 - $8.39 $11,735 - $20,555
2,450 New
2,450 $21,000
Q4 2017

Feb 07, 2018

SELL
$6.6 - $7.78 $90,750 - $106,975
-13,750 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$5.75 - $7.75 $79,062 - $106,562
13,750
13,750 $97,000

Others Institutions Holding CRBP

About Corbus Pharmaceuticals Holdings, Inc.


  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $720M
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.